| Analysis | Metabolite Name | Measured Value | Units | Sample type | Gender |
|---|---|---|---|---|---|
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 21027 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 26125 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 29566 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 2872286 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 3084551 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 3302656 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 3619544 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 3687701 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 3814729 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 3937114 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4034794 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4061393 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4082381 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4111247 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4137805 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4163619 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4166531 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4194184 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4231217 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4231459 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4255518 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4276825 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4303265 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4327794 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4330393 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4358130 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4371225 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4372484 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4386678 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4412617 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4435128 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4437356 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4442586 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4460215 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4480801 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4502138 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4507485 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4508136 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4547576 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4556402 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4575726 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4588591 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4589105 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4601568 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4612972 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4633442 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4641994 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4656401 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4664050 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4672535 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4676040 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4688541 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4702201 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4751398 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4752415 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4753913 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4778666 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4782135 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4797564 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4825259 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4838552 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4839754 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4863801 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4883681 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4897080 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4897157 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4905203 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4909874 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4930893 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4940403 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4950397 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4951129 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4980146 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 4992497 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5008544 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5014888 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5016153 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5018722 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5052532 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5055302 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5062798 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5080592 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5083283 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5094058 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5121074 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5121138 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5123936 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5142292 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5143807 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5145660 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5171858 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5173456 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5174381 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5179215 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5183118 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5189472 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5196749 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5209971 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5212095 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5226788 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5227452 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5233551 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5243855 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5248107 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5254989 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5261872 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5280481 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5282527 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5303360 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5307124 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5307915 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5325030 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5339587 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5346283 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5349332 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5360009 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5370538 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5372817 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5391944 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5396676 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5405890 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5413129 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5424749 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5429248 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5448584 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5453586 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5476868 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5477962 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5494267 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5513496 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5534859 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5537555 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5538608 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5579342 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5595974 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5604647 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5626807 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5627364 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5633530 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5635991 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5637906 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5674883 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5707377 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5747426 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5759828 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5769010 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5770994 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5786129 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5794946 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5795290 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5795894 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5796858 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5803108 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5858071 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5905951 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5935646 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5977736 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5985712 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 5992680 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6021189 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6034258 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6074526 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6085376 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6087482 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6103662 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6127958 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6129482 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6133660 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6147100 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6184997 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6192247 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6206969 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6212283 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6220357 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6261203 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6315041 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6339749 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6346439 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6351661 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6360046 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6361276 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6395386 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6403055 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6427903 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6432827 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6439018 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6461016 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6474476 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6488112 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6497690 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6502475 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6513097 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6515144 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6516050 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6516835 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6519859 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6543306 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6546303 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6548514 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | SM(d36:2) | 6548583 | Peak area normalized | Sample | male |
Return to search page
